Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays?Giovanna Garufi, Fabio Puglisi, Anna Ventriglia et al.|Cancer Treatment Reviews|2022Cited by 20